fluxd.news

Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors · fluxd.news

LIVE

Fintech

Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors

Globenewswire·April 16, 2026 at 11:30 AM

WALTHAM, Mass., April 16, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and...

Original Source

Globenewswire — www.globenewswire.com

Related in Fintech

X Money Tests Whether Social Commerce Can Hold Consumer Deposits
PYMNTS
Beaten-down digital asset treasury names lead crypto stock surge as bitcoin hits
CoinDesk
Bitcoin retakes $78,000 as Trump declares Hormuz ‘open and ready for business’
The Block
Sen. Blumenthal presses DOJ and Treasury on Binance monitor amid Iran sanctions
The Block